comparemela.com

Latest Breaking News On - பெருநிறுவன மூத்தவர் துணை ப்ரெஸிடெஂட் - Page 1 : comparemela.com

Boehringer Ingelheim Enters Clinical Collaboration with Amgen to Study BI 1701963, a SOS1::pan-KRAS Inhibitor, in Combination with LUMAKRAS (sotorasib), a KRASG12C Inhibitor

Boehringer Ingelheim Enters Clinical Collaboration with Amgen to Study BI 1701963, a SOS1::pan-KRAS Inhibitor, in Combination with LUMAKRAS (sotorasib), a KRASG12C Inhibitor
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

TII appoints eminent technologist as CEO

Technology Innovation Institute (TII), the applied research pillar of the Advanced Technology Research Council (ATRC), has announced the appointment of veteran technologist and entrepreneur Dr Ray O. Johnson as Chief Executive Officer.

Technology Innovation Institute Appoints Eminent Technologist Dr Ray O Johnson as CEO

ABU DHABI, United Arab Emirates (BUSINESS WIRE) Aug 2, 2021 Technology Innovation Institute (TII), the applied research pillar of the Advanced Technology Research Council (ATRC), the overarching advanced technology body in Abu Dhabi responsible for driving research and development for transformative technology outcomes, today announced the appointment of veteran technologist and entrepreneur Dr Ray O. Johnson as Chief Executive Officer. Dr Johnson will work on shaping the strategic direction of the Institute and lead the execution of its growth strategies to achieve operational excellence. Dr Ray O. Johnson, Chief Executive Officer, Technology Innovation Institute (Photo: AETOSWire) Prior to joining TII, Dr Johnson was an Operating Partner at Bessemer Venture Partners, a top-tier American venture capital company that has been part of 130 IPOs in the last 50 years, and before that, he was the Corporate Senior Vice President for Engineering, Technology, and Operations and Chief Tec

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.